Highlights from ASCO 2020

PARP inhibitors in prostate cancer: Guidelines, who to test and the patient pathway

Conducting Oncology Clinical Trials in Africa II: ACTC Informational Session

Timing of response to venetoclax combination treatment in older patients with acute myeloid leukaemia

ASCO 2020: Latest developments in EGFR-mutated non-small cell lung cancer

Ensuring quality care for breast cancer patients globally

E2108: Systemic therapy plus early local therapy versus systemic therapy alone in women with de novo stage IV breast cancer

Denosumab in multiple myeloma patients with renal insufficiency

ADAURA results: Adjuvant osimertinib for EGFRm non-small cell lung cancer

COVID-19: Treating breast cancer and the knock on effects of the coronavirus pandemic

Conducting Oncology Clinical Trials in Africa II: AC3T - Assessing, profiling, and building cancer clinical trial capacity in Africa

Perioperative use of NSAIDs reduces risk of early relapse in breast cancer